Anove-LogoAnove-LogoExplAIn
KartenKI-Vorreiter
Zurück zum Verzeichnis

ChestEye Quality

von Oxipit

AI Application
Niedrige Vertrauensstufe

ChestEye Quality is quality-assurance software for chest X-rays, used in radiology departments to catch findings that a radiologist's final report missed. Oxipit now markets it as 'Quality' within its CXR Suite; in its EUDAMED registration it is one of four functions of the ChestEye device, described as identifying potential reporting errors made by radiologists. The vendor says it analyses the final report together with the image, using a deep neural network on the X-ray, and flags discrepancies in near-real time; it can also audit large image archives retrospectively. Oxipit says a second human radiologist first reviews the flags, and only confirmed suspicions go to the reporting radiologist by email, with a heat map marking the area, for another look; the hospital can assign one of its own radiologists to that review. Oxipit says ChestEye is usually installed on the hospital's premises, with cloud deployment possible, and works on anonymised data; it names no hosting provider. Oxipit has been part of Sectra since 2026.

Website besuchen

Transparenz-Score

Gewichtet über vier Säulen · aktualisiert October 20, 2026

Gesamtnote
33% gewichtet
ABCDF
Modell
—
Noch nicht bewertet
Infrastruktur
—
Noch nicht bewertet

Funktionen

Missed Finding Detection
Report Image Discrepancy Check
Retrospective Quality Audit
Radiologist Notification

Anbieterinformationen

Vollständige Informationen zum Anbieter/Provider dieser KI-Anwendung

OxipitAlle Produkte ansehen →
Sectra Lithuania, UAB(Handelsname: Oxipit (part of Sectra))
Kontaktinformationen
oxipit.ai
info@oxipit.ai
Registrierte Adresse
Saulėtekio al. 15-1, Vilnius, Vilnius County, LT-10224, LT

Anbieterinformationen gemäß EU AI Act

Verifizierungsstatus:
Unverified
(Zuletzt verifiziert: October 20, 2026)
Sectra Lithuania, UAB(Handelsname: Oxipit (part of Sectra))
Saulėtekio al. 15-1, Vilnius, Vilnius County, LT-10224, LT
info@oxipit.ai
Compliance-Dokumente
CE-Kennzeichnung: Certified
Benannte Stelle: TÜV Rheinland LGA Products GmbH(Zertifikat: HZ 1550682-1)
Oxipit says ChestLink reports autonomously only on studies where it is highly confident there are no abnormalities, leaves any study with 'the slightest suspicion' to the radiologist, and recommends retrospective analysis and supervised operation before autonomous reporting (https://oxipit.ai/article/autonomous-ai-medical-imaging-understanding-chestlink/, 5 Apr 2022, read 2026-10-20). In the Finnish primary-care study it cites, ChestLink identified 36.4% of studies without significant findings at 99.8% sensitivity, with nine false negatives (slightly enlarged heart, slightly increased opacification, a small pleural effusion) among 9,579 cases (https://oxipit.ai/products/chestlink/, read 2026-10-20). The vendor refers users to the user guide for indications, contraindications and warnings; it is not public (https://oxipit.ai/regulatory-compliance-and-certifications/, read 2026-10-20).
Compliance & Risiken

Erhalten Sie Einblicke in Risiken, indem Sie Bewertungen für diese KI-Anwendung durchführen.

Arbeiten Sie bei Oxipit? Übernehmen Sie diesen Eintrag, um die Daten zu korrigieren oder zu vervollständigen.

Hinzugefügt: October 20, 2026
Aktualisiert: October 20, 2026

Bereit, KI-Anwendungen zu verwalten?

Verfolgen, bewerten und steuern Sie Ihre KI-Anwendungen mit Anove.

Anove-LogoAnove-LogoAnove International B.V.

Wir helfen Organisationen, KI-Anwendungen verantwortungsvoll zu entdecken und zu verwalten. Ihre vertrauenswürdige Quelle für KI-Governance und Compliance.

Schnellzugriffe

  • Verzeichnis durchsuchen
  • FAQ
  • KI-Karten nach Branche
  • Anmelden

Ressourcen

  • Dokumentation
  • Status
  • Anove.ai

Rechtliches

  • Datenschutzerklärung
  • AGB
  • Responsible Disclosure
  • KI-Rechtshinweis
  • Sicherheitsrichtlinie

© 2026 Anove International B.V. Alle Rechte vorbehalten.